Eradication of minimal residual disease improves overall and progression free survival in patients with chronic lymphocytic leukaemia, evidence from NCRN CLL207: A Phase II trial assessing alemtuzumab consolidation.

Varghese, A, Howard, DR orcid.org/0000-0003-3333-9783, Pocock, C et al. (9 more authors) (2017) Eradication of minimal residual disease improves overall and progression free survival in patients with chronic lymphocytic leukaemia, evidence from NCRN CLL207: A Phase II trial assessing alemtuzumab consolidation. British Journal of Haematology, 176 (4). pp. 573-582. ISSN 0007-1048

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2016 John Wiley & Sons Ltd. This is the peer reviewed version of the following article: Varghese, A. M., Howard, D. R., Pocock, C., Rawstron, A. C., Follows, G., McCarthy, H., Dearden, C., Fegan, C., Milligan, D., Smith, A. F., Gregory, W., Hillmen, P. and NCRI CLL Sub-Group (2016), Eradication of minimal residual disease improves overall and progression-free survival in patients with chronic lymphocytic leukaemia, evidence from NCRN CLL207: a phase II trial assessing alemtuzumab consolidation. British Journal of Haematology. doi: 10.1111/bjh.14342, which has been published in final form at https://doi.org/10.1111/bjh.14342. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Self-Archiving.
Keywords: Chronic lymphocytic leukaemia; minimal residual disease; alemtuzumab
Dates:
  • Published: February 2017
  • Accepted: 13 July 2016
  • Published (online): 29 December 2016
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > Institute of Molecular Medicine (LIMM) (Leeds) > Section of Experimental Haematology (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 28 Jul 2016 14:11
Last Modified: 29 Dec 2017 01:38
Published Version: https://doi.org/10.1111/bjh.14342
Status: Published
Publisher: Wiley
Identification Number: https://doi.org/10.1111/bjh.14342

Share / Export

Statistics